2024. Results of a Phase 2 Multicenter Study to Evaluate the Efficacy of VP-315, an Investigational Therapy for Basal Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s481. DOI:https://doi.org/10.25251/skin.8.supp.481.